Below are the most recent publications written about "Tumor Necrosis Factor-alpha" by people in Profiles.
-
Matteucci KC, Leite NPS, Assis PA, Hirako IC, Pioto F, Ojelabi O, Toller-Kawahisa JE, Vaz LG, Costa DL, da Silva JS, Alves-Filho JC, Gazzinelli RT. Reprogramming of host energy metabolism mediated by the TNF-iNOS-HIF-1? axis plays a key role in host resistance to Plasmodium infection. Elife. 2026 Jul 27; 13.
-
Deshpande C, Khanduja S, Rondthaler SN, Andrews LB, Forbes NS. Suppression of Salmonella Effectors with CRISPRi Controls the Immune Response to Bacterial Therapies. ACS Synth Biol. 2026 Jul 17; 15(7):2912-2924.
-
Lentini G, Coppolino F, Famà A, De Gaetano GV, Grasso F, Fiore L, Berbiglia A, Carnevale S, Venza I, Lien E, Venza M, Jaillon S, Teti G, Beninati C. Caspase-8 silences cell death-independent constitutive immune activation driven by tonic TNF-?. EMBO Rep. 2026 07; 27(14):4054-4078.
-
Nishimi K, Linnstaedt SD, Neylan TC, McKibben LA, Albertorio-Sáez LM, Zhao Y, House SL, Beaudoin FL, An X, Stevens JS, Clifford GD, Jovanovic T, Germine LT, Rauch SL, Haran JP, Storrow AB, Musey PI, Hendry PL, Sheikh S, Punches BE, Swor RA, Pascual JL, Seamon MJ, Datner EM, Pearson C, Peak DA, Merchant RC, Domeier RM, Rathlev NK, O'Neil BJ, Sergot P, Sanchez LD, Bruce SE, Harte SE, Kessler RC, Koenen KC, Ressler KJ, McLean SA, O'Donovan A. Inflammatory markers in the emergency department and PTSD symptoms in the AURORA Study: A longitudinal cohort study. Psychol Med. 2026 05 08; 56:e123.
-
Gonçalves-Pereira MH, Queiroz-Glauss C, Figueiredo MM, Quintino-de-Carvalho IL, Ramos MF, Bento GA, Magalhães TVB, Mafra AA, Diniz LMO, Costa ÚLD, Gollob KJ, Nogueira ML, Antonelli LRDV, Santiago HDC. DENV-Specific IL-10-Producing Regulatory T Cells Are Associated With Mild Clinical Outcomes in Dengue. J Med Virol. 2026 May; 98(5):e70956.
-
Shaikh FS, Shanta MA, Singh AK, Daniels AM, Khuder SA, Thiele GM, Reed GW, Kremer JM, Pappas DA, Curtis JR, O'Dell JR, Ouseph MM, Fox DA, Ahmed S. TWEAK receptor (Fn14) exacerbates TNF-?-induced inflammation in rheumatoid arthritis synovial fibroblasts and influences response to anti-TNF-? therapy. Cell Mol Immunol. 2026 03; 23(3):315-328.
-
de Souza Silva L, Monks BG, Forconi CS, Crabtree JN, De Paula Tamburro N, Kurt-Jones EA, Gazzinelli RT, Fitzgerald KA, Golenbock DT. Interleukin-10 limits immune-mediated pathology in chronic subclinical plasmodial infection. PLoS Negl Trop Dis. 2025 09; 19(9):e0013554.
-
Sang-Ngern M, Fukuchi A, Kondratyuk TP, Park EJ, Simmons CJ, Wall MM, Lorch SE, Pezzuto JM, Chang LC. Biologically active withanolides from Physalis peruviana. Pharm Biol. 2025 Dec; 63(1):334-343.
-
Ogdie A, Reddy SM, Gillespie SH, Husni ME, Scher JU, Salomon-Escoto K, Kay J, Luedders BA, Curtis JR, Shields AJS, Chakravarty SD, Gong C, Walsh JA. Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trial. Trials. 2025 Mar 19; 26(1):96.
-
Han Y, Guo X, Thanuphol P, Ji R, Zhu Z, Wu Y, Du H, Xiao H. Gut Microbiota-Mediated Degradation of Food-Grade Lambda-Carrageenan by Bacteroides xylanisolvens and Its Role in Inflammation. J Agric Food Chem. 2025 Feb 19; 73(7):4288-4298.